For the Inventor, By the Inventor

Enter assignee name

Tucson, AZ, United States of America

Imarx Pharmaceutical Corporation

Calculating rank

USPTO Granted Patents = 63

% Expired Patents = 3.2

CIPO Patents = 1

Forward Citations = 6,196

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Evan C Unger (63 out of 134 patents)

Guanli Wu (17 out of 30 patents)

David W Yellowhair (16 out of 21 patents)

4. Terry Onichi Matsunaga (13 out of 25 patents)

5. Thomas A Fritz (12 out of 24 patents)

6. VaradaRajan Ramaswami (10 out of 15 patents)

7. DeKang Shen (6 out of 10 patents)

8. Thomas McCreery (5 out of 8 patents)

9. Yunqiu Wu (3 out of 7 patents)

10. Frederick Scott Pereles (3 out of 3 patents)

11. Edward W Gertz (2 out of 2 patents)

12. Terrence R Barrette (2 out of 2 patents)

13. Thomas P Mc Creery (1 out of 1 patent)

Core Competencies:

Therapeutic Delivery

Ultrasound Imaging

Contrast Agents

Gas-Filled Liposomes

Biocompatible Polymers

Optoacoustic Imaging

Magnetic Resonance Imaging

Cationic Lipids

Prodrugs

Diagnostic Imaging

Computed Tomography

Lipid Soluble Compounds

63 patents: Sort by Forward Citations

1. 7612033 - Methods for delivering compounds into a cell (2009-11-03),

2. 7329402 - Methods of imaging and treatment (2008-02-12),

3. 6743779 - Methods for delivering compounds into a cell (2004-06-01),

4. 6638767 - Methods for delivering compounds into a cell (2003-10-28),

5. 6443898 - Therapeutic delivery systems (2002-09-03),

6. 6231834 - Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same (2001-05-15),

7. 6146657 - Gas-filled lipid spheres for use in diagnostic and therapeutic (2000-11-14),

8. 6143276 - Methods for delivering bioactive agents to regions of elevated (2000-11-07),

9. 6139819 - Targeted contrast agents for diagnostic and therapeutic use (2000-10-31),

10. 6123923 - Optoacoustic contrast agents and methods for their use (2000-09-26),

11. 6120751 - Charged lipids and uses for the same (2000-09-19),

12. 6117414 - Method of computed tomography using fluorinated gas-filled lipid (2000-09-12),

13. 6090800 - Lipid soluble steroid prodrugs (2000-07-18),

14. 6088613 - Method of magnetic resonance focused surgical and therapeutic ultrasound (2000-07-11),

15. 6071495 - Targeted gas and gaseous precursor-filled liposomes (2000-06-06),

Company Overview

Imarx Pharmaceutical Corporation, based in Tucson, AZ, specializes in innovative therapeutic delivery systems aimed at enhancing medical imaging and treatment efficacy. The company focuses on developing advanced technologies such as ultrasound imaging, contrast agents, and gas-filled liposomes, which are designed to improve the precision and effectiveness of therapeutic interventions. Their expertise extends to biocompatible polymers, optoacoustic imaging, magnetic resonance imaging, and cationic lipids, positioning them at the forefront of medical technology advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

63 Patents

#11 in Tucson, AZ

#67 in Arizona

#5,769 in US

#11,634 in the World

Tucson, AZ, United States of America

Imarx Pharmaceutical Corporation

Forward Citations = 6,196

13 inventors:

Evan C Unger (63 out of 134 patents)

Guanli Wu (17 out of 30 patents)

David W Yellowhair (16 out of 21 patents)

4. Terry Onichi Matsunaga (13 out of 25 patents)

5. Thomas A Fritz (12 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Imarx Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/imarx-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…